INCR
Price
$1.56
Change
+$0.08 (+5.41%)
Updated
Jul 3 closing price
Capitalization
123.5M
43 days until earnings call
RGC
Price
$22.99
Change
+$12.63 (+121.91%)
Updated
Jul 3 closing price
Capitalization
50.75M
Interact to see
Advertisement

INCR vs RGC

Header iconINCR vs RGC Comparison
Open Charts INCR vs RGCBanner chart's image
Intercure
Price$1.56
Change+$0.08 (+5.41%)
Volume$25.22K
Capitalization123.5M
Regencell Bioscience Holdings
Price$22.99
Change+$12.63 (+121.91%)
Volume$18.8M
Capitalization50.75M
INCR vs RGC Comparison Chart in %
Loading...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INCR vs. RGC commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCR is a Hold and RGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (INCR: $1.56 vs. RGC: $22.99)
Brand notoriety: INCR and RGC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: INCR: 192% vs. RGC: 553%
Market capitalization -- INCR: $123.5M vs. RGC: $50.75M
INCR [@Pharmaceuticals: Other] is valued at $123.5M. RGC’s [@Pharmaceuticals: Other] market capitalization is $50.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCR’s FA Score shows that 1 FA rating(s) are green whileRGC’s FA Score has 0 green FA rating(s).

  • INCR’s FA Score: 1 green, 4 red.
  • RGC’s FA Score: 0 green, 5 red.
According to our system of comparison, INCR is a better buy in the long-term than RGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCR’s TA Score shows that 3 TA indicator(s) are bullish while RGC’s TA Score has 4 bullish TA indicator(s).

  • INCR’s TA Score: 3 bullish, 4 bearish.
  • RGC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both INCR and RGC are a bad buy in the short-term.

Price Growth

INCR (@Pharmaceuticals: Other) experienced а +4.70% price change this week, while RGC (@Pharmaceuticals: Other) price change was +13.87% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

INCR is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCR($124M) has a higher market cap than RGC($50.8M). RGC YTD gains are higher at: 17584.475 vs. INCR (-1.887). INCR has higher annual earnings (EBITDA): 25.8M vs. RGC (-4.67M). INCR has more cash in the bank: 103M vs. RGC (306K). RGC has less debt than INCR: RGC (3.54M) vs INCR (163M). INCR has higher revenues than RGC: INCR (415M) vs RGC (0).
INCRRGCINCR / RGC
Capitalization124M50.8M244%
EBITDA25.8M-4.67M-552%
Gain YTD-1.88717584.475-0%
P/E Ratio22.52N/A-
Revenue415M0-
Total Cash103M306K33,660%
Total Debt163M3.54M4,601%
FUNDAMENTALS RATINGS
INCR vs RGC: Fundamental Ratings
INCR
RGC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
84100
PRICE GROWTH RATING
1..100
5734
P/E GROWTH RATING
1..100
4100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INCR's Valuation (59) in the Servicestothe Health Industry industry is somewhat better than the same rating for RGC (94) in the Movies Or Entertainment industry. This means that INCR’s stock grew somewhat faster than RGC’s over the last 12 months.

INCR's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that INCR’s stock grew similarly to RGC’s over the last 12 months.

INCR's SMR Rating (84) in the Servicestothe Health Industry industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that INCR’s stock grew similarly to RGC’s over the last 12 months.

RGC's Price Growth Rating (34) in the Movies Or Entertainment industry is in the same range as INCR (57) in the Servicestothe Health Industry industry. This means that RGC’s stock grew similarly to INCR’s over the last 12 months.

INCR's P/E Growth Rating (4) in the Servicestothe Health Industry industry is significantly better than the same rating for RGC (100) in the Movies Or Entertainment industry. This means that INCR’s stock grew significantly faster than RGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INCRRGC
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRMD0.09N/A
+0.70%
MariMed Inc.
KPCPF4.60N/A
N/A
KASIKORNBANK Public Co. Ltd.
MCUJF0.91N/A
N/A
Medicure Inc.
PTIZF1.32N/A
N/A
PT Indo Tambangraya Megah
KOGL57.00N/A
N/A
Kopp Glass, Inc.

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and PHCUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and PHCUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+5.41%
PHCUF - INCR
26%
Poorly correlated
N/A
KMDA - INCR
24%
Poorly correlated
+1.81%
TLRY - INCR
22%
Poorly correlated
+11.03%
QNTM - INCR
22%
Poorly correlated
-10.96%
AKAN - INCR
21%
Poorly correlated
+5.38%
More

RGC and

Correlation & Price change

A.I.dvisor tells us that RGC and CLCFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and CLCFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
+121.91%
CLCFF - RGC
21%
Poorly correlated
N/A
QNTM - RGC
21%
Poorly correlated
-10.96%
SBFM - RGC
20%
Poorly correlated
-6.06%
INCR - RGC
8%
Poorly correlated
+5.41%
KMDA - RGC
6%
Poorly correlated
+1.81%
More